U.S. Home Infusion Therapy Market Size, Share & Trends Analysis Report by Product (Infusion Pumps, Needleless Connectors), Application (Anti-Infective, Endocrinology), and Segment Forecasts, 2024-2030

The U.S. home infusion therapy market size is expected to reach USD 31.8 billion by 2030, according to the report. The market is anticipated to expand at a CAGR of 7.7% from 2024 to 2030. The growing geriatric population and increasing prevalence of disorders, such as cancer, immune deficiencies, Crohn's disease, infections, dehydration, nutritional deficiencies, multiple sclerosis, nausea, and vomiting are majorly driving the market’s growth. The increasing need for reduced hospital stays and the rising prevalence of chronic disorders in the geriatric population are driving the growth.

Growing cases of Hospital Acquired Infections (HAI) is another major factor driving the growth of the U.S. home infusion therapy industry over the forecast period. According to the U.S. Centers for Disease Control and Prevention, approximately 1.7 million admitted patients are affected annually by Healthcare Acquired infections (HCAIs) and around 98, 000 patients (1 in 17 patients) die due to the same. Due to this, the demand for home infusion therapy is increasing substantially.

Increasing innovations in home infusion therapy such as the incorporation of electronic healthcare records along with medical devices and infusion pumps are trending. It allows storage, retrieval, and alteration of medical records, making it easier for healthcare professionals and patients to track the improvements in a particular disorder.

Increasing patients’ preference for home healthcare since it is cost-efficient in comparison with hospital stays is an opportunity for the industry players to launch more innovative products. Also, the introduction of safety products will ultimately help the growth of the U.S. home infusion therapy market. The advent of COVID-19 boosted the home infusion market in the country as many key players like Baxter, BD, ICU Medical, and Option Care Health, Inc reported revenue increases for their home infusion products and services in 2020 and 2021. This trend is expected to further boost the market as numerous healthcare settings in the country are expected to permanently opt for home infusion services to decrease patient admission burden in hospitals and other healthcare facilities

U.S. Home Infusion Therapy Market Report Highlights

The infusion pumps segment held the largest revenue share compared to others due to the increasing use and efficiency in delivering required quantities of nutrition, medications, and other essential fluids
The needleless connectors segment is expected to witness the fastest growth owing to various benefits, such as less risk of bacterial contamination and higher protection against needle stick injuries
The anti-infective segment held the maximum revenue share in 2023 owing to its extensive use as an antifungal, antibiotic, and antiviral agent at home care
Endocrinology is predicted to be the fastest-growing segment owing to the growing number of conditions associated with the endocrine system, such as thyroid and diabetes

Chapter 1 Methodology and Scope

1.1 Market Segmentation and Scope
1.1.1 Estimates and forecast timeline
1.2 Research Methodology
1.3 Information procurement
1.3.1 Purchased database:
1.3.2 Internal database
1.3.3 Secondary sources
1.3.4 Primary research
1.3.5 Details of primary research
1.4 Information or Data Analysis
1.4.1 Data analysis models
1.5 Market Formulation & Validation
1.6 Model Details
1.6.1 Commodity Flow Analysis (Model 1)
1.6.1.1 Approach 1: Commodity Flow Approach
1.7 List of Secondary Sources
1.8 Objectives
1.8.1 Objective 1
1.8.2 Objective 2
1.8.3 Objective 3
1.8.4 Objective 4

Chapter 2 Executive Summary

2.1 Market Outlook
2.2 Penetration & Growth Prospect Mapping
2.3 Market Dynamics
2.3.1 Market driver analysis
2.3.1.1 Increasing geriatric population
2.3.1.2 Rising prevalence of chronic disorders
2.3.1.3 Rapid technological advancements
2.3.1.4 Growing incidence of hospital-acquired infections
2.3.1.5 Home healthcare as a cost-effective alternative
2.3.2 Market restrain analysis
2.3.2.1 Presence of complicated reimbursement framework and reimbursement cuts
2.3.3 Impact Of The 21st Century Cures Act And Projections For The Impact Of The Bipartisan Budget Act Of 2018.
2.3.4 Trends For Home Infusion For Medicare Part B And Medicare Part D
2.4 U.S. Home Infusion Therapy: Market Analysis Tools
2.4.1 Industry analysis - Porter’s
2.4.2 PESTLE analysis
2.5 U.S Home Infusion Therapy- Company Market Share Analysis 2023
2.6 Major Deals & Strategic Alliances Analysis
2.7 Procedure cost analysis/breakdown
2.8 Technology Timeline
2.9 Regulatory Framework
2.10 Reimbursement framework

Chapter 3 U.S Home Infusion Therapy Market: Segment Analysis, By Product, 2018 - 2030 (USD Million)

3.1 Product Market Share Analysis, 2023 & 2030
3.2 U.S. Home Infusion Therapy Market, by Product, 2023 to 2030
3.3 Market Size & Forecasts and Trend Analyses, 2023 to 2030
3.3.1 Infusion pumps
3.3.1.1 Infusion Pumps Market, 2018 - 2030 (USD Million)
3.3.1.2 Elastomeric Market, 2018 - 2030 (USD Million)
3.3.1.3 Electromechanical Market, 2018 - 2030 (USD Million)
3.3.1.4 Gravity Market, 2018 - 2030 (USD Million)
3.3.1.5 Others Market, 2018 - 2030 (USD Million)
3.3.2 Intravenous sets
3.3.3 Intravenous Sets Market, 2018 - 2030 (USD Million)
3.3.4 Gravity Sets Market, 2018 - 2030 (USD Million)
3.3.5 Dedicated Sets Market, 2018 - 2030 (USD Million)
3.3.6 IV Cannulas
3.3.6.1 IV Cannulas Market, 2018 - 2030 (Usd Million)
3.3.7 Needleless Connectors
3.3.7.1 Needleless Connectors Market, 2018 - 2030 (USD Million)

Chapter 4 U.S. Home Infusion Therapy Market: Segment Analysis, By Application, 2018 - 2030 (USD Million)

4.1 Application Market Share Analysis, 2023 & 2030
4.2 U.S. Home Infusion Therapy Market, by Application, 2023 to 2030
4.3 Market Size & Forecasts and Trend Analyses, 2023 to 2030
4.3.1 Anti-Infective
4.3.1.1 Anti-infective market, 2018 - 2030 (USD Million)
4.3.2 endocrinology
4.3.2.1 ENDOCRINOLOGY MARKET, 2018 - 2030 (USD Million)
4.3.2.2 Diabetes market, 2018 - 2030 (USD Million)
4.3.2.3 Others market, 2018 - 2030 (USD Million)
4.3.3 Hydration therapy
4.3.3.1 hydration therapy market, 2018 - 2030 (USD Million)
4.3.3.2 Athletes market, 2018 - 2030 (USD Million)
4.3.3.3 Others market, 2018 - 2030 (USD Million)
4.3.4 Chemotherapy
4.3.4.1 CHEMOTHERAPY MARKET, 2018 - 2030 (USD Million)
4.3.5 Enteral nutrition
4.3.5.1 ENTERAL NUTRITION market, 2018 - 2030 (USD Million)
4.3.6 Parenteral nutrition
4.3.6.1 PARENTERAL NUTRITION market, 2018 - 2030 (USD Million)
4.3.7 Specialty pharmaceuticals
4.3.7.1 SPECIALTY PHARMACEUTICALS MARKET, 2018 - 2030 (USD Million)
4.3.8 Others
4.3.8.1 Others market, 2018 - 2030 (USD Million)

Chapter 5 Home Infusion Therapy Market: Country Market Analysis, By Product, 2018 - 2030 (USD Million)

5.1 Market Size, & Forecasts and Trend Analysis, 2023 to 2030
5.2 U.S.
5.2.1 U.S. Home Infusion Therapy market, by product, 2018 - 2030 (USD Million)
5.2.2 U.S. Home Infusion Therapy market, by Appliction, 2018 - 2030 (USD Million)

Chapter 6 Home Infusion Therapy Market - Competitive Analysis

6.1 Competitive Dashboard Analysis - Impact Analysis
6.1.1 Recent Developments & Impact Analysis, By Key Market Participants
6.2 Company/Competition Categorization (Key innovators, Market leaders, Emerging players)
6.2.1 List of key innovators
6.2.2 List of market leader
6.2.3 List of emerging players
6.3 Company market position analysis (Revenue, product portfolio, key serviceable industries, key alliances)
6.3.1 By Revenue
6.4 Strategy Framework
6.5 Company Profiles
6.5.1 B. Braun Melsungen AG
6.5.1.1 Company overview
6.5.1.2 Financial performance
6.5.1.3 Product benchmarking
6.5.1.4 Strategic initiatives
6.5.2 Baxter
6.5.2.1 Company overview
6.5.2.2 Financial performance
6.5.2.3 Product benchmarking
6.5.2.4 Strategic initiatives
6.5.3 Caesarea Medical Electronics
6.5.3.1 Company overview
6.5.3.2 Product benchmarking
6.5.3.3 Strategic initiatives
6.5.4 CareFusion Corporation
6.5.4.1 Company overview
6.5.4.2 Financial performance
6.5.4.3 Product benchmarking
6.5.4.4 Strategic initiatives
6.5.5 Fresenius Kabi AG
6.5.5.1 Company overview
6.5.5.2 Financial performance
6.5.5.3 Product benchmarking
6.5.5.4 Strategic initiatives
6.5.6 ICU Medical, Inc.
6.5.6.1 Company overview
6.5.6.2 Financial performance
6.5.6.3 Product benchmarking
6.5.6.4 Strategic initiatives
6.5.7 JMS Co., Ltd.
6.5.7.1 Company overview
6.5.7.2 Financial performance
6.5.7.3 Product benchmarking
6.5.8 Smiths Medical
6.5.8.1 Company overview
6.5.8.2 Financial performance
6.5.8.3 Product benchmarking
6.5.8.4 Strategic initiatives
6.5.9 Terumo Corporation
6.5.9.1 Company overview
6.5.9.2 Financial performance
6.5.9.3 Product benchmarking
6.5.9.4 Strategic initiatives
6.5.10 Coram LLC
6.5.10.1 Company overview
6.5.10.2 Product benchmarking
6.5.11 Option Care Enterprises, Inc.
6.5.11.1 Company overview
6.5.11.2 Financial performance
6.5.11.3 Product benchmarking
6.5.11.4 Strategic initiatives
6.5.12 BioScrip, Inc.
6.5.12.1 Company overview
6.5.12.2 Financial performance
6.5.12.3 Product benchmarking
6.5.12.4 Strategic initiatives
6.5.13 BriovaRx Infusion Services
6.5.13.1 Company overview
6.5.13.2 Financial performance
6.5.13.3 Product benchmarking
6.5.13.4 Strategic initiatives
6.6.14 Paragon Healthcare, Inc.
6.6.14.1 Company overview
6.6.14.2 Financial performance
6.6.14.3 Product benchmarking

List of Tables

Table 1 List of secondary sources
Table 2 U.S. Home Infusion Therapy market, leading market players per region
Table 3 U.S. Home Infusion Therapy market, Regional Network Map
Table 4 U.S. Home Infusion Therapy market, market differentiating factor

List of Figures

Fig. 1 U.S. home infusion therapy market segmentation
Fig. 2 Market research process
Fig. 3 Information procurement
Fig. 4 Primary research pattern
Fig. 5 Market research approaches
Fig. 6 Value-chain-based sizing & forecasting
Fig. 7 Market formulation & validation
Fig. 8 Commodity flow analysis
Fig. 9 Market outlook (2023)
Fig. 10 Penetration & growth prospect mapping
Fig. 11 Market driver relevance analysis (Current & future impact)
Fig. 12 U.S. population over 60 years by age, 1900 - 2050
Fig. 13 Prevalence of chronic disease in the U.S.
Fig. 14 Treatment cost by healthcare setting (Average cost per day in USD)
Fig. 15 Market restraint relevance analysis (Current & future impact)
Fig. 16 Porter’s five forces analysis
Fig. 17 PESTLE analysis
Fig. 18 U.S. Home Infusion Therapy market: Company market share analysis, 2023
Fig. 19 U.S. Home Infusion Therapy market: Company market share analysis, 2023
Fig. 20 U.S. Home Infusion Therapy Market: Product movement analysis
Fig. 21 U.S. Home Infusion Therapy Market Product Outlook: Key takeaways
Fig. 22 Infusion pumps market, 2018 - 2030 (USD Million)
Fig. 23 Elastomeric market, 2018 - 2030 (USD Million)
Fig. 24 Electromechanical market, 2018 - 2030 (USD Million)
Fig. 25 Gravity market, 2018 - 2030 (USD Million)
Fig. 26 Others market, 2018 - 2030 (USD Million)
Fig. 27 Intravenous sets market, 2018 - 2030 (USD Million)
Fig. 28 Intravenous sets market, 2018 - 2030 (USD Million)
Fig. 29 Dedicated sets market, 2018 - 2030 (USD Million)
Fig. 30 IV cannulas market, 2018 - 2030 (USD Million)
Fig. 31 Needleless connectors market, 2018 - 2030 (USD Million)
Fig. 32 U.S. home infusion therapy market: Application movement analysis
Fig. 33 Home infusion therapy market application outlook: Key takeaways
Fig. 34 Anti-infective market, 2018 - 2030 (USD Million)
Fig. 35 Endocrinology market, 2018 - 2030 (USD Million)
Fig. 36 Diabetes market, 2018 - 2030 (USD Million)
Fig. 37 Others market, 2018 - 2030 (USD Million)
Fig. 38 Hydration therapy market, 2018 - 2030 (USD Million)
Fig. 39 Athletes market, 2018 - 2030 (USD Million)
Fig. 40 Others market, 2018 - 2030 (USD Million)
Fig. 41 Chemotherapy market, 2018 - 2030 (USD Million)
Fig. 42 Enteral nutrition market, 2018 - 2030 (USD Million)
Fig. 43 Parenteral nutrition market, 2018 - 2030 (USD Million)
Fig. 44 Specialty pharmaceuticals market, 2018 - 2030 (USD Million)
Fig. 45 Others market, 2018 - 2030 (USD Million)
Fig. 46 U.S. Country Dynamics
Fig. 47 Recent Developments & Impact Analysis
Fig. 48 Strategy Framework

Companies Profiled

B. Braun Melsungen AG
Baxter
Caesarea Medical Electronics
CareFusion Corporation
Fresenius Kabi AG
ICU Medical, Inc.
JMS Co., Ltd.
Smiths Medical
Terumo Corporation
Coram LLC
Option Care Enterprises, Inc.
BioScrip, Inc.
BriovaRx Infusion Services
Paragon Healthcare, Inc.

Methodology

LOADING...

Table Information

Report Attribute	Details
No. of Pages	116
Published	November 2023
Forecast Period	2023 - 2030
Estimated Market Value ( USD ) in 2023	$ 19.1 Billion
Forecasted Market Value ( USD ) by 2030	$ 31.8 Billion
Compound Annual Growth Rate	7.7%
Regions Covered	United States
No. of Companies Mentioned	14

License	Format	Properties	Price
SINGLE USER LICENSE PDF	The product is a PDF.	This is a single user license, allowing one user access to the product.	€3456EUR$3,500USD£2,886GBP
1 - 5 USER LICENSE PDF	The product is a PDF.	This is a 1-5 user license, allowing up to five users have access to the product.	€4443EUR$4,500USD£3,710GBP
ENTERPRISE LICENSE PDF	The product is a PDF.	This is an enterprise license, allowing all employees within your organization access to the product.	€6418EUR$6,500USD£5,360GBP

U.S. Home Infusion Therapy Market Report Highlights

Table of Contents

Companies Profiled

Methodology

Table Information

Related Topics

Related Reports

Elastomeric Infusion Pumps Market Size, Share & Trends Analysis Report By Product (Continuous Rate Elastomeric Infusion Pumps, Variable Rate Elastomeric Infusion Pumps), By Application, By End Use, By Region, And Segment Forecasts, 2024 - 2030

Intraosseous Infusion Devices Market Size, Share & Trends Analysis Report By Type (Manual IO Needles, Battery Powered Driver), By End-use (Hospitals and Clinics, Ambulatory Surgical Centers), By Region, And Segment Forecasts, 2024 - 2030

Home Infusion Services Market by Product, Indication, Application - Global Forecast 2025-2030

Home Infusion Therapy Market: Analysis By Product (Infusion Pumps, Intravenous Sets, IV Cannulas, and Needleless Connectors), By Application, By Route of Administration (Intramuscular, Subcutaneously, and Epidural), By Region Size and Trends and Forecast to 2028

Home Infusion Therapy - Global Strategic Business Report